The clinical audit summarizes the results of 1,107 bariatric surgery cases performed between 2007-2014. It finds that the mini-gastric bypass (MGB) procedure has the best outcomes in terms of excess weight loss, resolution of comorbidities like diabetes and hypertension, and lowest rates of complications and mortality. Specifically, MGB achieved 92.18% excess weight loss, resolved 94.37% of diabetes cases, and had 0% mortality. In comparison, laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RNY) had lower success rates. Based on these findings, the audit recommends MGB as the procedure of choice for treating morbid obesity.
Endocrine issues swirl around the Bariatric patient: Diabetes, thyroid conditions, and more. What do clinicians need to be aware of when caring for these patients pre or post surgery? What are the unique endocrinologic issues which explain the mechanism of success with bariatric surgery? Learn here.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay
Surgical Management of Obesity درمان جراحی چاقی
انواع اعمال جراحی :
محدود کننده جذب :
گاسترینگ باندینگ قابل تنظیم لاپاراسکوپیک
گاسترکتومی آسینی
مختل کننده جذب مواد غذایی :
انحراف صفراوی پانکراسی
سوئیچ دئودنال
ترکیبی :
بای پس معده
گاستریک باندینگ قابل تنظیم لاپاراسکوپیکLAGB
قرار دادن یک نوار سیلیکونی بادشونده دور قسمت پروگزیمال معده که نوار به یک سیستم مخزنی که اجازه تنظیم سفتی نوار را فراهم می آورد متصل می شود. این سیستم مخزنی به وسیله یک پورت زیرجلدی قابل دسترس می شود.
دونوع نوار برای این روش استفاده می شود :
lap-bandگاستریک باندینگ قابل تنظیم
گاستریک باندینگ قابل تنظیم سوئدی
این عمل جراحی بیشتر به صورت سرپایی انجام می شود وچون دستگاه گوارش مورد تهاجم قرار نمی گیرد خطر نسبی این عمل کمتر از اعمال دیگر است.
بیمارانی که برای کاهش وزن ناشکیبا هستند ، بی تحرک هستند ، قادر به ورزش نیستند و انتظار دارند که بتوانند به عادات غذایی قبلی خود بدون تغییر ادامه دهند کاندید خوبی برای این عمل نیستند.
تنظیمات باند و جلسات گروه حمایتی پس از عمل برای نتایج خوب بسیار مهم هستند.تنظیمات باند مانند بخشی از جراحی مهم است.
توافق کلی این است که کاهش کمتر از دو پوند در هفته اندیکاسیون افزایش محدودیت باند با اضافه کردن مایع است.
نتایج:
به طور میانگین 5تا7 سال بعد از عمل بیماران به ترتیب 60% و 58% از وزن اضافی را کم کردند.
هایپرتانسیون در 55% بیماران طی یک سال برطرف شده
آپنه انسدادی به 2%کاهش داشته
آسم و افسردگی بهبود داشته
در بیش از 50% موارد بهبودی داشته GERD
عوارض:
- پرولاپس: قسمت تحتانی معده به سمت بالا هل داده شده و در لومن باند گیر می کند.نیازبه جراحی دوباره دارد.
- سرخورردن
- صدمه بافتی به خاطر فرسودگی باند
- عوارض پورت و لوله هاَ
شکست در کاهش وزن بیشتر از اعمال دیگر رخ می دهد.
Endocrine issues swirl around the Bariatric patient: Diabetes, thyroid conditions, and more. What do clinicians need to be aware of when caring for these patients pre or post surgery? What are the unique endocrinologic issues which explain the mechanism of success with bariatric surgery? Learn here.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay
Surgical Management of Obesity درمان جراحی چاقی
انواع اعمال جراحی :
محدود کننده جذب :
گاسترینگ باندینگ قابل تنظیم لاپاراسکوپیک
گاسترکتومی آسینی
مختل کننده جذب مواد غذایی :
انحراف صفراوی پانکراسی
سوئیچ دئودنال
ترکیبی :
بای پس معده
گاستریک باندینگ قابل تنظیم لاپاراسکوپیکLAGB
قرار دادن یک نوار سیلیکونی بادشونده دور قسمت پروگزیمال معده که نوار به یک سیستم مخزنی که اجازه تنظیم سفتی نوار را فراهم می آورد متصل می شود. این سیستم مخزنی به وسیله یک پورت زیرجلدی قابل دسترس می شود.
دونوع نوار برای این روش استفاده می شود :
lap-bandگاستریک باندینگ قابل تنظیم
گاستریک باندینگ قابل تنظیم سوئدی
این عمل جراحی بیشتر به صورت سرپایی انجام می شود وچون دستگاه گوارش مورد تهاجم قرار نمی گیرد خطر نسبی این عمل کمتر از اعمال دیگر است.
بیمارانی که برای کاهش وزن ناشکیبا هستند ، بی تحرک هستند ، قادر به ورزش نیستند و انتظار دارند که بتوانند به عادات غذایی قبلی خود بدون تغییر ادامه دهند کاندید خوبی برای این عمل نیستند.
تنظیمات باند و جلسات گروه حمایتی پس از عمل برای نتایج خوب بسیار مهم هستند.تنظیمات باند مانند بخشی از جراحی مهم است.
توافق کلی این است که کاهش کمتر از دو پوند در هفته اندیکاسیون افزایش محدودیت باند با اضافه کردن مایع است.
نتایج:
به طور میانگین 5تا7 سال بعد از عمل بیماران به ترتیب 60% و 58% از وزن اضافی را کم کردند.
هایپرتانسیون در 55% بیماران طی یک سال برطرف شده
آپنه انسدادی به 2%کاهش داشته
آسم و افسردگی بهبود داشته
در بیش از 50% موارد بهبودی داشته GERD
عوارض:
- پرولاپس: قسمت تحتانی معده به سمت بالا هل داده شده و در لومن باند گیر می کند.نیازبه جراحی دوباره دارد.
- سرخورردن
- صدمه بافتی به خاطر فرسودگی باند
- عوارض پورت و لوله هاَ
شکست در کاهش وزن بیشتر از اعمال دیگر رخ می دهد.
Dr Pravin John and Dr John Thanakumar, Anurag Hospital, Coimbatore present the differences between metabolic and obesity surgery - dept of advanced laparoscopy and obesity
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...Dr Pradeep Jain Reviews
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight Loss. Dr Pradeep Jain Fortis has wide experience of Gastroenterology Surgery.
Bone health of postpartum women: Unexpected high prevalence of a health probl...Premier Publishers
The aim was to see the effect of pregnancy on Bone Mineral Density (BMD) and bone turnover markers (BTMs) in the immediate postpartum period and 12 months thereafter. Eighty women delivered at KAUH (May 2009-Oct 2010) had BMD, bone profile, 25-OH vitamin D and (BTMs). Inclusion criteria: Singleton pregnancy without medical or pregnancy complications. Exclusion criteria: multiple pregnancies, history of diabetes thyroid or bone disease, and use of any medication that affect calcium metabolism. Biochemical tests were repeated for 27 women after one year. Statistical analysis was done using SPSS 16. Eighty women had BMD before discharge. Sixty four women (80%) had low BMD; sixteen of these (25%) had osteoporosis. Although bone profiles were normal, Vitamin D levels were moderately or severely deficient in 35.37% of women. After adjustment for BMI and age there was no correlation between BMD and other variables. Multiple linear regressions showed that BMI was the predictor for BMD (P=0.0014). There was no significant difference between postpartum bone BTMs and bone profiles, and those after twelve months.
Osteoporosis/ osteopenia is a significant health problem in this group of women. Further studies are needed to look into predisposing factors.
Bariatric surgery is gaining popularity worldwide. The number of surgeries has increased by almost 10 times in the last decade and almost 14000 bariatric surgery were performed last year in India.
Tenslotte zal Prof. Dr. Joop van den Bergh het fractuurrisico bij patiënten met DM type 1 en 2 bespreken: hoe relevant is het verhoogde fractuurrisico bij jonge patiënten met DM type 1? Zijn adipeuze patiënten met DM type 2 beschermd tegen osteoporose? Welke determinanten spelen een rol bij het fractuurrisico bij DM type 2?
Dr Pravin John and Dr John Thanakumar, Anurag Hospital, Coimbatore present the differences between metabolic and obesity surgery - dept of advanced laparoscopy and obesity
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...Dr Pradeep Jain Reviews
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight Loss. Dr Pradeep Jain Fortis has wide experience of Gastroenterology Surgery.
Bone health of postpartum women: Unexpected high prevalence of a health probl...Premier Publishers
The aim was to see the effect of pregnancy on Bone Mineral Density (BMD) and bone turnover markers (BTMs) in the immediate postpartum period and 12 months thereafter. Eighty women delivered at KAUH (May 2009-Oct 2010) had BMD, bone profile, 25-OH vitamin D and (BTMs). Inclusion criteria: Singleton pregnancy without medical or pregnancy complications. Exclusion criteria: multiple pregnancies, history of diabetes thyroid or bone disease, and use of any medication that affect calcium metabolism. Biochemical tests were repeated for 27 women after one year. Statistical analysis was done using SPSS 16. Eighty women had BMD before discharge. Sixty four women (80%) had low BMD; sixteen of these (25%) had osteoporosis. Although bone profiles were normal, Vitamin D levels were moderately or severely deficient in 35.37% of women. After adjustment for BMI and age there was no correlation between BMD and other variables. Multiple linear regressions showed that BMI was the predictor for BMD (P=0.0014). There was no significant difference between postpartum bone BTMs and bone profiles, and those after twelve months.
Osteoporosis/ osteopenia is a significant health problem in this group of women. Further studies are needed to look into predisposing factors.
Bariatric surgery is gaining popularity worldwide. The number of surgeries has increased by almost 10 times in the last decade and almost 14000 bariatric surgery were performed last year in India.
Tenslotte zal Prof. Dr. Joop van den Bergh het fractuurrisico bij patiënten met DM type 1 en 2 bespreken: hoe relevant is het verhoogde fractuurrisico bij jonge patiënten met DM type 1? Zijn adipeuze patiënten met DM type 2 beschermd tegen osteoporose? Welke determinanten spelen een rol bij het fractuurrisico bij DM type 2?
Sleeve vs Mini-Gastric Bypass
IN EVERY STUDY, by every measure, the Mini-Gastric Bypass is equal to or better than every other form of bariatric surgery
The Mini-Gastric Bypass: Best Treatment Type 2 Diabetes Mellitus
Dr K S Kular
Kular Medical Education & Research Society ,
Kular Group of Institutes ,
drkskular@gmail.com
www.kularhospital.com
Why Consider the MGB?
With the Band/Sleeve/RNY available
Why even consider the Mini-Gastric Bypass?
6 yr study 29,820 BCBS plan members.
"Laparoscopic RNY and Lap Band both Fail to reduce overall health care costs in the long term."
Impact of Bariatric Surgery on Health Care Costs of Obese Persons, A 6-Year Follow-up of Surgical and Comparison Cohorts Using Health Plan Data Jonathan P. Weiner, et al. JAMA Surg. 2013;148(6)
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Clinical Audit of Sleeve Gastrectomy, RNY & MGB to find safe and effective Bariatric & Metabolic Procedure
1. CLINICAL AUDIT
January 2007 to March 2014
For Effective and Safe
BARIATRIC & METABOLIC PROCEDURE
Dr. G. S. Jammu
MS, FAIS
Director cum Chief Bariatric Surgeon
JAMMU HOSPITAL, JALANDHAR (PUNJAB) INDIA
Email : drgsjammu@gmail.com • www.jammuhospital.com
2. Disclosures
Dr. G. S. Jammu
MS, FAIS
Director cum Chief Bariatric Surgeon
No Disclosure
3. Introduction
Obesity is complex disease, its epidemic is increasing not only
in developed countries but also in developing countries like
India. Obesity leads to many diseases like T2D, hypertension,
sleep apnea and fatty liver disease.
Bray, G.A. 1999. “Nutrition and obesity: Prevention and treatment”, Journal of Nutrition
Metabolic Cardiovascular Disease 9: 21-32.
4. Introduction
In 2013, 13% people were obese world wide. India is the
third most obese country with figures as high as 30 million.
In India problem is associated with under nutrition and the
significant proportion of overweight and obese people now
coexist. (Popkin, 2002).
• Lancet Journal
• Popkin, 2002
5. Objectives
Primary
To formulate safe & effective surgical policy for bariatric and
metabolic procedures.
Secondary
To analyze the post operative complications developed in
respective procedures by comparing LSG, RNY and MGB in
bariatric surgery.
6. Material and Methods
Audit is based on retrospective study carried out at a
single centre Jammu Hospital Jalandhar, India
from Jan 2007 to March 2014
by a Medical Audit Committee
• Bariatric Surgeon
• Physician
• Anesthetist
• Bariatric Counselor
• Nutritionist
7. A Inclusion Criteria for complication part :
All 1,107 cases (87 months period).
B Inclusion Criteria for EWL & resolution of comorbidities
part :
Cases with mean follow-up of 53.5 months (Max. 87
months and Min. 20 months)
Material and Methods
8. A Data Collection
(Complication Part)
------------------------------------------------------------------------------------------
Sample size : 1107 cases
------------------------------------------------------------------------------------------
Female : 63.0% (697) Male : 37.0% (410)
------------------------------------------------------------------------------------------
Mean Age : 46.5 Years (18-72 Years) Mean BMI : 42 (30-72)
------------------------------------------------------------------------------------------
T2D : 48.6% (538) HTN : 47.7% (528) Dyslipidemia : 42.7% (473)
------------------------------------------------------------------------------------------
LSG : 339 (30.6%) RNY : 295 (26.5%) MGB : 473 (42.7%)
------------------------------------------------------------------------------------------
Mean Surgery Time (Mins.) :
MGB : 57.5 (42-75) RNY : 160.5 (123-198) LSG : 60 (45-75)
------------------------------------------------------------------------------------------
9. Comorbidities
T2D : 29.0% (118)
HTN : 30.7% (125)
Dyslipidemia : 28.5% (116)
B Data Collection
EWL & Resolution of Comorbidities
( Mean follow-up of 53.5 months)
Types of Surgeries
LSG : 97 (23.83%)
RNY : 143 (35.13%)
MGB : 167 (41.03%)
Total sample size : 407 cases
10. 1. Complications
a. Life threatening Complications
b. Non Life threatening Complications
2. Benefits
EWL & Resolution of Comorbidities
Observations
11. Prevalence of Iron, folate & Vitamin B12 deficiency anemia after laparoscopic Roux-en-y gastric bypass. Vargas-Rulz AG,
Hernonlez Rivera G, Herrera MI, Obes Surgery 2008 Mar. 18 (3), 288-93
Nutritional Deficiencies following Bariatric Surgery: What Have We Learned? Richard D. Bloomberg, MD, FRCSC; Amy
Fleishman, MS, RD, CDN; Jennifer E. Nalle, RN, MS, FNP; Daniel M. Herron, MD, FACS; Subhash Kini, MD, FRCS
After gastric bypass surgery : Managing medical & surgical disorder : Macronutrient & Micronutrient disorders. Bikram
Bal, MD, Timothy R. Koch, MD, Frederick C Fineli, MD, JD, Michael G.Sars, MD. CME Released 5/11/2010.
Complication External
Bleeding
Internal
Bleeding
Leaks Pulmonary
Embolism
& DVT
Respiratory
Failure
Persistent
vomiting
Anaemia Mortality Hypo
Albumin-
emia
LSG 1.42 0.44 0.71 1.33 3.56 2.14
RNY 0.625 0.625 0.625 4.05 0.625
Standard
RNY
1.9
-----------
Distal
RNY
14.0
MGB 1 0.5 4.52 13.1
Observations
Life Threatening Complications
12. Complication External
Bleeding
Internal
Bleeding
Leaks Pulmonary
Embolism
& DVT
Respiratory
Failure
Persistent
vomiting
Anaemia Mortality Hypo
Albumin-
emia
LSG 1.42 0.44 0.71 1.33 3.56 2.14
RNY 0.625 0.625 0.625 4.05 0.625
Standard
RNY
1.9
-----------
Distal
RNY
14.0
MGB 1 0.5 4.52 13.1
Observations
Life Threatening Complications
Prevalence of Iron, folate & Vitamin B12 deficiency anemia after laparoscopic Roux-en-y gastric bypass. Vargas-Rulz AG,
Hernonlez Rivera G, Herrera MI, Obes Surgery 2008 Mar. 18 (3), 288-93
Nutritional Deficiencies following Bariatric Surgery: What Have We Learned? Richard D. Bloomberg, MD, FRCSC; Amy
Fleishman, MS, RD, CDN; Jennifer E. Nalle, RN, MS, FNP; Daniel M. Herron, MD, FACS; Subhash Kini, MD, FRCS
After gastric bypass surgery : Managing medical & surgical disorder : Macronutrient & Micronutrient disorders. Bikram
Bal, MD, Timothy R. Koch, MD, Frederick C Fineli, MD, JD, Michael G.Sars, MD. CME Released 5/11/2010.
13. Hypoalbuminemia in MGB
The high incidence of hypoalbuminemia was noticed in longer bypass
more than 230 cm.
In all the cases in which length of bypass was 200 cm or less, the
incidence of hypalbuminemia was not seen.
Except in one patient who had 200 cm bypass and hypoalbuminemia
was 3.0 g/dl. This patient was suffering from diabetic nephropathy. To
control the falling albumin levels in this patient we had to pay special
attention on his nutrition part and it was seen once patient started having
protein rich diet his level improved.
14. Step 1
• Nutritional Supplementation
• In patients with Albumin Level between 2.6-3.5 g/dl
Step 2
• Reversal of Bypass
• In patients with persistant Albumin Levels below 2.5 g/dl with ankle
oedema
Management of
Hypoalbuminemia in MGB
15. Management of
Hypoalbuminemia in MGB
1 case of hypoalbuminemia had to be reversed.
All other cases of mild hypoalbuminemia responded to good nutritional
supplementation in the form of high protein diet and did not require any
intervention.
Now in all our patients the length of bypass is 200 cm and no
hypoalbuminemia is found in these patients.
16. Management of Hypoalbuminemia
in Distal RNY
Revision Surgery is difficult, long and cumbersome.
Reversal requires revision of two anastamosis.
17. Complication Nausea Dumping Internal
Hernia
Constipation Hair Loss GERD Weight
Regain
Less of
Excess
weight loss
Gall Stone
Formation
LSG 8 2.23 8 9.82 14 13.39 4.46
RNY 4.29 2.73 2.34 2.73 8 1.56 8 6.25 7.03
MGB 7.81 5.93 1.87 10 0.625 8.75
Predictors of gallstone formation after bariatric surgery : a multivariate analysis of risk factor
compassing gastric bypass, gastric banding & sleeve gastrectomy. LIVK, Pulido N, Fajnwaks P,
Szomstein S, Rosenthal R, Sury Endasc. 2008 Dec 5.
Bile reflux after Roux-en-Y gastric bypass; an unrecognized cause of postoperative pain. Swartz DE,
Modley E, Felix EL, Sury Obes, Retat DA. 2009 Jan-Feb; 5(1):27-30.
Observations
Non-Life Threatening Complications
18. Complication Nausea Dumping Internal
Hernia
Constipation Hair Loss GERD Weight
Regain
Less of
Excess
weight loss
Gall Stone
Formation
LSG 8 2.23 8 9.82 14 13.39 4.46
RNY 4.29 2.73 2.34 2.73 8 1.56 8 6.25 7.03
MGB 7.81 5.93 1.87 10 0.625 8.75
Predictors of gallstone formation after bariatric surgery : a multivariate analysis of risk factor
compassing gastric bypass, gastric banding & sleeve gastrectomy. LIVK, Pulido N, Fajnwaks P,
Szomstein S, Rosenthal R, Sury Endasc. 2008 Dec 5.
Bile reflux after Roux-en-Y gastric bypass; an unrecognized cause of postoperative pain. Swartz DE,
Modley E, Felix EL, Sury Obes, Retat DA. 2009 Jan-Feb; 5(1):27-30.
Observations
Non-Life Threatening Complications
19. LSG RNY MGB
Excess Weight Loss 53.57 72.26 92.18
Dyslipidemia 55.80 75 93.43
T2D 59.37 76.17 94.37
Hypertension 45.98 72.65 84.06
EWL & Resolution of Comorbidities
Bariatric surgery and diabetes remission : sleeve gastrectomy or mini gastric bypass ? Marco Milone,
Matteo Nicola Dario Di Minno, Maddalena Leongito, Paola Maietta, Paolo Bianco, Caterina Taffuri, Dario
Gaudioso, Roberta Lupoli, Silvia Savastano, Francesco Milone, and Mario Musella J Gastroenterol. Oct
21, 2013; 19(39): 6590–6597.
The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a
multicenter review. Musella M1, Susa A, Greco F, De Luca M, Manno E, Di Stefano C, Milone M, Bonfanti
R, Segato G, Antonino A, Piazza L. Surg. Endosc. 2014 Jan 28(1), 156-63
20. LSG RNY MGB
Excess Weight Loss 53.57 72.26 92.18
Dyslipidemia 55.80 75 93.43
T2D 59.37 76.17 94.37
Hypertension 45.98 72.65 84.06
EWL & Resolution of Comorbidities
Bariatric surgery and diabetes remission : sleeve gastrectomy or mini gastric bypass ? Marco Milone,
Matteo Nicola Dario Di Minno, Maddalena Leongito, Paola Maietta, Paolo Bianco, Caterina Taffuri, Dario
Gaudioso, Roberta Lupoli, Silvia Savastano, Francesco Milone, and Mario Musella J Gastroenterol. Oct
21, 2013; 19(39): 6590–6597.
The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a
multicenter review. Musella M1, Susa A, Greco F, De Luca M, Manno E, Di Stefano C, Milone M, Bonfanti
R, Segato G, Antonino A, Piazza L. Surg. Endosc. 2014 Jan 28(1), 156-63
21. Summary
Audit indicted that …
Mortality rate was 2.14 % in cases with LSG and 0.625 % in RNY
and NIL in MGB.
Leaks were highest in LSG (1.42 %) followed by RNY (0.625 %) and NIL
in MGB.
Persistent vomiting was in LSG only.
Weight regain was 14 % in LSG and 8 % in RNY but Nil in MGB.
Hypoalbuminemia was minimal in LSG, 1.9% in Standard RNY, 14% in
Distal RNY and 13.1% in MGB.
Resolution of Comorbidities like Dyslipidemia, T2D, Hypertension,
Excess Weight Loss was maximum in MGB
22. Obesity surgery results depending on technique performed; Long term outcome. Grecia JA,
Martinez M, Ella M, Agculella V, Royo P, Jimenez A, Bielsa MA, Arribas D, Obes Sury. 2008 Nov 12
Benefits Excess weight loss Mortality Weight regain Hypertension T2D resolved Dyslipidemia
LSG
53.57 2.14 14 45.98 59.37 55.80
RNY
72.26 0.625 8 72.65 76.17 75
MGB 92.18 0 0 84.06 94.37 93.43
So, Why MGB ?
23. Obesity surgery results depending on technique performed; Long term outcome. Grecia JA,
Martinez M, Ella M, Agculella V, Royo P, Jimenez A, Bielsa MA, Arribas D, Obes Sury. 2008 Nov 12
Benefits Excess weight loss Mortality Weight regain Hypertension T2D resolved Dyslipidemia
LSG
53.57 2.14 14 45.98 59.37 55.80
RNY
72.26 0.625 8 72.65 76.17 75
MGB 92.18 0 0 84.06 94.37 93.43
So, Why MGB ?
25. Conclusions
• On the basis of audit we concluded that MGB which is a
combination of sleeve and bypass is technically more easy to
perform in minimum time period comparative to LSG and RNY.
• Above all mortality rate was zero in MGB.
• EWL and resolution of comorbidities was highly significant in
our audit which simply makes MGB the simplest and most
effective procedure.
26. Policy
On the basis of this audit we suggest MGB is the procedure of
choice in patients with morbid obesity, who are compliant in taking
their vitamins, calcium and iron supplements.
LSG maybe done in non-compliant patients and who are ready to
accept weight regain.
RNY and MGB both procedures act on the same principle of
restriction and malabsorption but MGB supersedes RNY in its
technique, efficacy, reversibility and revisibility.